Effects of margarines and butter consumption on lipid profiles, inflammation markers and lipid transfer to HDL particles in free-living subjects with the metabolic syndrome


Autoria(s): GAGLIARDI, A. C. M.; MARANHAO, R. C.; SOUSA, H. P. de; SCHAEFER, E. J.; SANTOS, R. D.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2010

Resumo

Objective: Our purpose was to examine the effects of daily servings of butter, no-trans-fat margarine and plant sterol margarine, within recommended amounts, on plasma lipids, apolipoproteins (Apos), biomarkers of inflammation and endothelial dysfunction, and on the transfer of lipids to HDL particles in free-living subjects with the metabolic syndrome. Methods: This was a randomized, single-blind study where 53 metabolic syndrome subjects (62% women, mean age 54 years) received isocaloric servings of butter, no-trans-fat margarine or plant sterol margarine in addition to their usual diets for 5 weeks. The main outcome measures were plasma lipids, Apo, inflammatory and endothelial dysfunction markers (CRP, IL-6, CD40L or E-selectin), small dense LDL cholesterol concentrations and in vitro radioactive lipid transfer from cholesterol-rich emulsions to HDL. Difference among groups was evaluated by analysis of variance. Results: There was a significant reduction in Apo-B (-10.4 %, P = 0.043) and in the Apo-B/Apo-A-1 ratio (-11.1%, P = 0.034) with plant sterol margarine. No changes in plasma lipids were noticed with butter and no-trans-fat margarine. Transfer rates of lipids to HDL were reduced in the no-trans-fat margarine group: triglycerides -42.0%, (P<0.001 vs butter and sterol margarine) and free cholesterol -16.2% (P = 0.006 vs sterol margarine). No significant effects were noted on the concentrations of inflammatory and endothelial dysfunction markers among the groups. Conclusions: In free-living subjects with the metabolic syndrome consumption of plant sterol and no-trans-fat margarines within recommended amounts reduced, respectively, Apo-B concentrations and the ability of HDL to accept lipids. European Journal of Clinical Nutrition (2010) 64, 1141-1149; doi:10.1038/ejcn.2010.122; published online 21 July 2010

CNPq Conselho Nacional de Desenvolvimento Cientifico e Pesquisa (National Research and Scientific Council) of Brazil

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

US Department of Agriculture

Identificador

EUROPEAN JOURNAL OF CLINICAL NUTRITION, v.64, n.10, p.1141-1149, 2010

0954-3007

http://producao.usp.br/handle/BDPI/19568

10.1038/ejcn.2010.122

http://dx.doi.org/10.1038/ejcn.2010.122

Idioma(s)

eng

Publicador

NATURE PUBLISHING GROUP

Relação

European Journal of Clinical Nutrition

Direitos

restrictedAccess

Copyright NATURE PUBLISHING GROUP

Palavras-Chave #butter #margarine #plant sterol #metabolic syndrome #HDL #inflammation #CORONARY HEART-DISEASE #HIGH-DENSITY-LIPOPROTEIN #CHOLESTEROL LEVELS #DIETARY PORTFOLIO #PLANT STEROLS #FAT #MORTALITY #PROTEIN #SIZE #STATIN #Nutrition & Dietetics
Tipo

article

original article

publishedVersion